Patient Guide: A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 14 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06337032
Status: 🟢 Enrolling Now
Condition: HIV-1-infection
Phase: PHASE4

Where You Can Participate

This study is available at 14 locations across the country.

Top locations include:
  • • Buenos Aires,
  • • Panama City,
  • • Cape Town,
  • • And 11 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments - Join Clinical Trial NCTNCT06337032

How to Join This Clinical Trial - NCTNCT06337032

Learn how to participate in this PHASE4 trial studying an investigational therapy for HIV-1-infection. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HIV-1-infection. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HIV-1-infection
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06337032 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Buenos Aires, C1141 ACG - Argentina

Status: RECRUITING

Clinical Research Site

Panama City, 0816-00383 - Panama

Status: RECRUITING

Clinical Research Site

Cape Town, 7505 - South Africa

Status: RECRUITING

Clinical Research Site

Durban, 3629 - South Africa

Status: RECRUITING

Clinical Research Site

Johannesburg, 2038 - South Africa

Status: RECRUITING

Clinical Research Site

Johannesburg, 2112 - South Africa

Status: RECRUITING

Clinical Research Site

Paarl, 7626 - South Africa

Status: RECRUITING

Clinical Research Site

Pretoria, 0087 - South Africa

Status: RECRUITING

Clinical Research Site

Soweto, 2013 - South Africa

Status: RECRUITING

Clinical Research Site

Bangkok Noi, 10700 - Thailand

Status: RECRUITING

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for HIV-1-infection:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships